Terms: = Gastric cancer AND FGFR4, CD334, 2264, ENSG00000160867, P22455, MGC20292, TKF, JTK2 AND Prognosis
9 results:
1. mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers.
Cheng L; Wang Y; Qiu L; Chang Y; Lu H; Liu C; Zhang B; Zhou Y; Bai H; Xiong L; Zhong H; Nie W; Han B
J Transl Med; 2022 May; 20(1):247. PubMed ID: 35642038
[TBL] [Abstract] [Full Text] [Related]
2. Expression and clinical significance of paired- related homeobox 1 and Smad2 in gastric cancer.
Yang Z; Huang WX; Wang S; Yao JB; Da M
Eur J Cancer Prev; 2021 Mar; 30(2):154-160. PubMed ID: 32868636
[TBL] [Abstract] [Full Text] [Related]
3. Identification of a novel oncogenic mutation of fgfr4 in gastric cancer.
Futami T; Kawase T; Mori K; Asaumi M; Kihara R; Shindoh N; Kuromitsu S
Sci Rep; 2019 Oct; 9(1):14627. PubMed ID: 31601997
[TBL] [Abstract] [Full Text] [Related]
4. Chemo-resistant gastric cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus.
Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C
Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707
[TBL] [Abstract] [Full Text] [Related]
5. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract] [Full Text] [Related]
6. The genomic landscape of oesophagogastric junctional adenocarcinoma.
Chong IY; Cunningham D; Barber LJ; Campbell J; Chen L; Kozarewa I; Fenwick K; Assiotis I; Guettler S; Garcia-Murillas I; Awan S; Lambros M; Starling N; Wotherspoon A; Stamp G; Gonzalez-de-Castro D; Benson M; Chau I; Hulkki S; Nohadani M; Eltahir Z; Lemnrau A; Orr N; Rao S; Lord CJ; Ashworth A
J Pathol; 2013 Nov; 231(3):301-10. PubMed ID: 24308032
[TBL] [Abstract] [Full Text] [Related]
7. The correlations between the expression of fgfr4 protein and clinicopathological parameters as well as prognosis of gastric cancer patients.
Ye YW; Zhang X; Zhou Y; Wu J; Zhao C; Yuan L; Wang G; Du C; Wang C; Shi Y
J Surg Oncol; 2012 Dec; 106(7):872-9. PubMed ID: 22585711
[TBL] [Abstract] [Full Text] [Related]
8. Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
Ye YW; Zhou Y; Yuan L; Wang CM; Du CY; Zhou XY; Zheng BQ; Cao X; Sun MH; Fu H; Shi YQ
Cancer; 2011 Dec; 117(23):5304-13. PubMed ID: 21567388
[TBL] [Abstract] [Full Text] [Related]
9. The fibroblast growth factor receptor-4 Arg388 allele is associated with gastric cancer progression.
Ye Y; Shi Y; Zhou Y; Du C; Wang C; Zhan H; Zheng B; Cao X; Sun MH; Fu H
Ann Surg Oncol; 2010 Dec; 17(12):3354-61. PubMed ID: 20844967
[TBL] [Abstract] [Full Text] [Related]
